SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615219-16-000196
Filing Date
2016-06-09
Accepted
2016-06-09 12:29:32
Documents
1
Period of Report
2016-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_146548975991066.html 4  
1 FORM 4 wf-form4_146548975991066.xml 4 7688
  Complete submission text file 0001615219-16-000196.txt   9085
Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Westphal Christoph H (Reporting) CIK: 0001291961 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36812 | Film No.: 161705333

Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Issuer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations